Archaeal Symbiosis and Digoxin Status Modulates Evolution of Homo Sapiens and Homo Neanderthalis - Digoxin Is a Neanderthal Hormone

Ravikumar A. Kurup, Parameswara Achutha Kurup

Abstract


Introduction: The climate change and global warming/ice age results in endosymbiotic actinidic archaeal growth in the human system and cholesterol catabolism resulting in endogenous digoxin synthesis. The increased endosymbiotic archaeal growth detected in autism and matrilineal communities with increased incidence of autism and neanderthalic origin leads to the conclusion that digoxin acts as neanderthalic hormone. The increased endosymbiotic archaeal growth and resultant endogenous digoxin synthesis in relation to climate change and global warming results in neanderthalisation of homo sapiens and human disease resulting in homo sapien extinction. Digoxin can inhibit reverse transcriptase activity and RNA editing resulting in suppression of endogenous retroviral growth. This produces inhibition of HERV expression and jumping gene phenomena producing in adynamicity of the human genome. HERV related jumping genes are crucial in synaptic diversity, HLA expression and immunomodulation as well as metabolic diversity. Digoxin produces alteration in sodium-hydrogen exchange producing an acidic pH and acts like a growth factor producing stem cell transformation of adult cells. Stem cells have a distinct metabolism with increased glycolysis and suppression of PDH and mitochondrial function. This can result in cancer and metabolic syndrome. The digoxin interference with RNA editing can lead to mutated RNA viruses and wide spread RNA viral epidemics. The digoxin interference with HERV expression and RNA editing and resultant inhibition of genomic, metabolic, neural and immune diversity produces autoimmune disease, cancer, metabolic syndrome, degenerations, schizophrenia and autism which are increasing at epidemic rates in human population.
Materials and Methods: Endogenous digoxin levels and serum cytochrome F420 levels as a marker of archaeal growth were estimated in matrilineal communities, SLE, multiple sclerosis, parkinson’s disease, alzheimer’s disease, CNS glioma, multiple myeloma, metabolic syndrome x with CAD and CVA, schizophrenia and autism. 15 numbers were included in each group and each patient had an age and sex matched control. Endogenous digoxin was estimated by Elisa and cytochrome F420 estimated by spectrophotometry. The statistical analysis was done by ANOVA.
Results: Endogenous digoxin levels and cytochrome F420 levels were elevated in matrilineal neanderthalic communities, SLE, multiple sclerosis, parkinson’s disease, alzheimer’s disease, CNS glioma, multiple myeloma, metabolic syndrome x with CAD and CVA, schizophrenia and autism. Endogenous digoxin and cytochrome F420 levels were low in non-matrilineal homo sapien population.
Conclusion: Homo sapiens tend to have low levels of endosymbiotic actinidic archaea and low digoxin synthesis. Homo sapiens have low incidence of autoimmune disease, cancer, schizophrenia, autism and metabolic syndrome. The neanderthalisation of homo sapiens consequent to endosymbiotic actinidic archaeal growth and digoxin synthesis produces human pathology and extinction. Homo neanderthalis have higher rates of actinidic archaeal symbiosis and digoxin synthesis with higher incidence of autoimmune disease, cancer, schizophrenia, autism and metabolic syndrome. Actinidic archaeal secreted digoxin functions as a Neanderthal hormone.


Keywords


Global warming; Actinidic archaea; Digoxin; Hormone; Evolution; Extinction

Full Text:

PDF

References


Bastir, M., O’Higgins, P., & Rosas, A. (2007). Facial ontogeny in neanderthals and modern humans. Proc. Biol. Sci.; 274:1125–1132.

Bruner, E., Manzi, G., & Arsuaga, J. L. (2003). Encephalization and allometric trajectories in the genus homo: Evidence from the neandertal and modern lineages. Proc. Natl. Acad. Sci, 100, 15335-15340.

Courchesne, E., & Pierce, K. (2005). Brain overgrowth in autism during a critical time in development: Implications for frontal pyramidal neuron and interneuron development and connectivity. Int. J. Dev. Neuro. Sci, 23, 153-170.

Eswaran, V., Harpending. H., & Rogers, A. R. (2005). Genomics refutes an exclusively african origin of humans. Journal of Human Evolution, 49(1), 1-18.

Gooch, S. (2006). The dream culture of the neanderthals: guardians of the ancient wisdom. Wildwood House, London: Inner Traditions.

Gooch, S. (2008). The neanderthal legacy: Reawakening our genetic and cultural origins. Wildwood House, London: Inner Traditions.

Graves, P. (1991). New models and metaphors for the neanderthal debate. Current Anthropology, 32(5), 513-541.

Green, R. E., Krause, J., Briggs, A. W., Maricic, T., Stenzel, U., Kircher, M., Patterson, N., Li, H., …Svante P. (2010). A draft sequence of the neandertal genome. Science, 328, 710-722.

Kurtén, B. (1978). Den svarta tigern. Stockholm, Sweden: ALBA Publishing.

Kurup, R. A., & Kurup, P. A. (2012). Endosymbiotic actinidic archaeal mediated warburg phenotype mediates human disease state. Advances in Natural Science, 5(1), 81-84.

Mithen, S. J. (2005). The singing neanderthals: The origins of music, language, mind and body. London: Weidenfeld and Nicolson. ISBN 0-297-64317-7.

Morgan, E. (2007). The Neanderthal theory of autism, Asperger and ADHD; Restrieved from http://www.rdos.net/eng/asperger.htm.

Neubauer, S., Gunz, P., & Hublin, J. J. (2010). Endocranial shape changes during growth in chimpanzees and humans: A morphometric analysis of unique and shared aspects. J. Hum. Evol, 59, 555-566.

Sawyer, G. J., & Maley, B. (2005). Neanderthal reconstructed. The Anatomical Record Part B: The New Anatomist, 283B(1), 23-31.

Spikins, P. (2009). Autism, the integrations of ‘difference’ and the origins of modern human behaviour. Cambridge Archaeological Journa, 19(2), 179-201.

Weaver, T. D., & Hublin, J. J. (2009). Neandertal birth canal shape and the evolution of human childbirth. Proc. Natl. Acad. Sci, 106, 8151-8156.




DOI: http://dx.doi.org/10.3968/4382

DOI (PDF): http://dx.doi.org/10.3968/g6148

Refbacks

  • There are currently no refbacks.


Copyright (c)




Share us to:   


Reminder

How to do online submission to another Journal?

If you have already registered in Journal A, then how can you submit another article to Journal B? It takes two steps to make it happen:

1. Register yourself in Journal B as an Author

Find the journal you want to submit to in CATEGORIES, click on “VIEW JOURNAL”, “Online Submissions”, “GO TO LOGIN” and “Edit My Profile”. Check “Author” on the “Edit Profile” page, then “Save”.

2. Submission

Go to “User Home”, and click on “Author” under the name of Journal B. You may start a New Submission by clicking on “CLICK HERE”.

We only use the following emails to deal with issues about paper acceptance, payment and submission of electronic versions of our journals to databases:
caooc@hotmail.com; office@cscanada.net; office@cscanada.org
ans@cscanada.net;ans@cscanada.org

 Articles published in Advances in Natural Science are licensed under Creative Commons Attribution 4.0 (CC-BY).

 ADVANCES IN NATURAL SCIENCE Editorial Office

Address: 1020 Bouvier Street, Suite 400, Quebec City, Quebec, G2K 0K9, Canada.

Telephone: 1-514-558 6138
Website: Http://www.cscanada.net; Http://www.cscanada.org
E-mail:caooc@hotmail.com; office@cscanada.net

Copyright © 2010 Canadian Research & Development Centre of Sciences and Cultures